CIT-013
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for CIT-013, covering 2026-01-30 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013 [Phase 1]